HICKERSON, BRADY T.; DANIELS-WELLS, TRACY R.; PAYES, CRISTIAN; CLARK, LARS E.; CANDELARIA, PIERRE V.; BAILEY, KEVIN W.; SEFING, ERIC J.; ZINK, SAMANTHA; ZIEGENBEIN, JAMES; ABRAHAM, JONATHAN; HELGUERA, GUSTAVO; PENICHET, MANUEL L.; GOWEN, BRIAN B.

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

NATURE COMMUNICATIONS; Año: 2022 vol. 13

BOURGUIGNON, NATALIA; KARP, PAOLA; ATTALLAH, CAROLINA; CHAMORRO, DANIEL A.; OGGERO, MARCOS; BOOTH, ROSS; FERRERO, SOL; BHANSALI, SHEKHAR; PÉREZ, MAXIMILIANO S.; LERNER, BETIANA; HELGUERA, GUSTAVO

Large Area Microfluidic Bioreactor for Production of Recombinant Protein

Biosensors; Año: 2022 vol. 12

HELGUERA, G.

Evaluación clínica de una vacuna contra COVID-19 desde la perspectiva de un voluntario

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2021 vol. 81 p. 125 - 126

FERRERO, SOL; FLORES, MARIA D.; SHORT, CONNOR; VAZQUEZ, CECILIA A.; CLARK, LARS E.; ZIEGENBEIN, JAMES; ZINK, SAMANTHA; FUENTES, DANIEL; PAYES, CRISTIAN; BATTO, MARÍA V.; COLLAZO, MICHAEL; GARCÍA, CYBELE C.; ABRAHAM, JONATHAN; CORDO, SANDRA M.; RODRIGUEZ, JOSE A.; HELGUERA, GUSTAVO

Antibody-based inhibition of pathogenic new world hemorrhagic fever mammarenaviruses by steric occlusion of the human transferrin receptor 1 apical domain

JOURNAL OF VIROLOGY; Año: 2021 vol. 95

LURIA-PÉREZ, ROSENDO; CANDELARIA, PIERRE V.; DANIELS-WELLS, TRACY R.; RODRÍGUEZ, JOSÉ A.; HELGUERA, GUSTAVO; PENICHET, MANUEL L.

Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein

CYTOKINE.; Año: 2019 vol. 120 p. 220 - 226

HELGUERA, GUSTAVO FERNANDO

Antecedentes regulatorios de los medicamentos de origen biológico similares en Argentina

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2019 vol. 79 p. 428 - 429

GALLAGHER-JONES, MARCUS; GLYNN, CALINA; BOYER, DAVID R.; MARTYNOWYCZ, MICHAEL W.; HERNANDEZ, EVELYN; MIAO, JENNIFER; ZEE, CHIH-TE; NOVIKOVA, IRINA V.; GOLDSCHMIDT, LUKASZ; MCFARLANE, HEATHER T.; HELGUERA, GUSTAVO F.; EVANS, JAMES E.; SAWAYA, MICHAEL R.; CASCIO, DUILIO; EISENBERG, DAVID S.; GONEN, TAMIR; RODRIGUEZ, JOSE A.

Sub-ångström cryo-EM structure of a prion protofibril reveals a polar clasp

Nature Structural and Molecular Biology; Año: 2018 vol. 25 p. 131 - 134

BOURGUIGNON, NATALIA; ATTALLAH, CAROLINA; KARP, PAOLA; BOOTH, ROSS; PEÑAHERRERA, ANA; PAYÉS, CRISTIAN; OGGERO, MARCOS; PÉREZ, MAXIMILIANO S.; HELGUERA, GUSTAVO; LERNER, BETIANA

Production of monoclonal antibodies in microfluidic devices

INTEGRATIVE BIOLOGY; Año: 2018 vol. 10 p. 136 - 144

GEORG, MAXIMILIAN; FERNÁNDEZ-CABADA, TAMARA; BOURGUIGNON, NATALIA; KARP, PAOLA; PEÑAHERRERA, ANA B.; HELGUERA, GUSTAVO; LERNER, BETIANA; PÉREZ, MAXIMILIANO S.; MERTELSMANN, ROLAND

Development of image analysis software for quantification of viable cells in microchips

PLOS ONE; Año: 2018 vol. 13

LURIA-PÉREZ, ROSENDO; HELGUERA, GUSTAVO; RODRÍGUEZ, JOSÉ A.

Antibody-mediated targeting of the transferrin receptor in cancer cells

Boletín Médico del Hospital Infantil de México; Año: 2016 vol. 73 p. 372 - 379

PEÑAHERRERA, A.; PAYÉS, C.; SIERRA-RODERO, M.; VEGA, M.; ROSERO, G.; LERNER, B.; HELGUERA, G.; PÉREZ, M.S.

Evaluation of cell culture in microfluidic chips for application in monoclonal antibody production

MICROELECTRONIC ENGINEERING; Año: 2016 vol. 158 p. 126 - 129

ALMAGRO J. C.; GILLILAND G. L.; BREDEN F.; SCOTT J. K.; SOK D.; PAUTHNER M.; REICHERT J. M.; HELGUERA G.; ANDRABI R.; MABRY R.; BLÉRY M.; VOSS J. E.; LAURÉN J.; ABUQAYYAS L.; BARGHORN S.; BEN-JACOB E.; CROWE J. E. JR.; HUSTON J. S.; JOHNSTON S. A.; KRAULAND E.; LUND-JOHANSEN F.; MARASCO W. A.; PARREN P. W.; XU K. Y.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

MABS; Lugar: Austin, Texas; Año: 2014 p. 577 - 618

FU M.; MARESH E. L.; HELGUERA G.; KIYOHARA M,; QIN Y.; ASHKI N.; DANIELS-WELLS T. R.; AZIZ N.; GORDON L. K.; BRAUN J.; ELSHIMALI Y.; SOSLOW R. A.; PENICHET M. L.; GOODGLICK L.; WADEHRA M.

Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.

MOLECULAR CANCER THERAPEUTICS; Lugar: Philadelphia; Año: 2014 vol. 13 p. 902 - 915

BERNABEU E.; HELGUERA G.; LEGASPI M.J.; GONZALEZ L.; HOCHT C.; TAIRA C.; CHIAPPETTA D. A.

Paclitaxel-loaded PCL-TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane®

COLLOIDS AND SURFACES B-BIOINTERFACES; Lugar: Amsterdam; Año: 2014

DANIELS T. R.; HELGUERA G.; LEUCHTER R. K.; QUINTERO R.; KOZMAN M.; RODRÍGUEZ J. A.; ORTIZ-SÁNCHEZ E; MARTÍNEZ-MAZA O.; SCHULTES B. C.; NICODEMUS C. F.; PENICHET M. L.

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

BMC CANCER; Lugar: Londres; Año: 2013 p. 1 - 13

PASQUALI R. C.; HELGUERA G.

"True" Hydrophilic-Lipophilic Balance of Polyoxyethylene Fatty Acid Esters Nonionic Surfactants

JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY; Lugar: New York; Año: 2013 p. 716 - 721

DANIELS T. R.; HELGUERA G.; RODRÍGUEZ J. A.; LEOH L. S.; ERB M. A.; DIAMANTE G.; CASERO D.; PELLEGRINI M.; MARTINEZ-MAZA O.; PENICHET M. L.

Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1

TOXICOLOGY IN VITRO : AN INTERNATIONAL JOURNAL PUBLISHED IN ASSOCIATION WITH BIBRA.; Lugar: Amsterdam; Año: 2013 p. 220 - 231

HELGUERA P.; SEIGLIE J.; RODRIGUEZ J. A.; HANNA M.; HELGUERA G.; BUSCIGLIO J.

Adaptive downregulation of mitochondrial function in down syndrome.

CELL METABOLISM; Lugar: United States; Año: 2013 p. 132 - 140

DING H.; HELGUERA G.; RODRIGUEZ J. A.; MARKMAN J.; LURIA-PÉREZ R.; GANGALUM P.; PORTILLA-ARIAS J.; INOUE S.; DANIELS-WELLS T.; BLACK K.; HOLLER E.; PENICHET M. L.; LJUBIMOVA J. Y.

Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer

JOURNAL OF CONTROLLED RELEASE; Lugar: Amsterdam; Año: 2013 p. 322 - 329

NILVEBRANT J.; DUNLOP D. C.; SIRCAR A.; WURCH T.; FALKOWSKA E.; REICHERT J. M.; HELGUERA G.; PICCIONE E. C.; BRACK S.; BERGER S.

IBC´s 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society

MABS; Lugar: Austin, Texas; Año: 2012 vol. 4 p. 1 - 29

HELGUERA G.; JEMIELITY S.; ABRAHAM J.; CORDO S.; MARTINEZ G.; RODRÍGUEZ J. A.; BREGNI C.; WANG J. J.; FARZAN M.; PENICHET M. L.; CANDURRA N.; CHOE H.

An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all New World hemorrhagic fever arenaviruses

JOURNAL OF VIROLOGY; Lugar: Washington; Año: 2012 vol. 86 p. 4024 - 4028

DANIELS T. R.; BERNABEU E.; RODRÍGUEZ J. A.; PATEL S.; KOZMAN M.; CHIAPPETTA D. A.; HOLLER E.; LJUBIMOVA J. Y.; HELGUERA G.; PENICHET M. L.

Transferrin Receptors and the targeted delivery of therapeutic agents against cancer

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS; Lugar: Amsterdam; Año: 2012 vol. 1820 p. 291 - 317

DANIELS T. R.; LEUCHTER R.; QUINTERO R.; HELGUERA G.; RODRÍGUEZ J. A.; MARTINEZ-MAZA O.; SCHULTES B. C.; NICODEMUS C. F.; PENICHET M. L.

Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2012 p. 1 - 13

DANIELS T. R.; ORTIZ-SANCHEZ E.; LURIA-PÉREZ R.; QUINTERO R.; HELGUERA G.; BONAVIDA B.; MARTINEZ-MAZA O.; PENICHET M. L.

An Antibody-based Multifaceted Approach Targeting the Human Transferrin Receptor for the Treatment of B-cell Malignancies

JOURNAL OF IMMUNOTHERAPY; Lugar: Philadelphia; Año: 2011 vol. 34 p. 500 - 508

HELGUERA G.; RODRÍGUEZ J. A.; LURIA-PÉREZ R.; HENERY S.; CATTERTON P.; BREGNI C.; GEORGE T. C.; MARTINEZ-MAZA O.; PENICHET M. L.

Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry

JOURNAL OF IMMUNOLOGICAL METHODS; Año: 2011 p. 54 - 63

RODRÍGUEZ J. A.; LURIA-PÉREZ R.; LOPEZ-VALDES H. E.; DÍAZ-CANO D. C.; DANIELS T. R.; PATEL S.; AVILA D.; LEUCHER R.; SO S.; ORTIZ-SANCHEZ E.; BONAVIDA B.; MARTINEZ-MAZA O.; CHARLES A. C.; PELLEGRINI M.; HELGUERA G.; PENICHET M. L.

Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2011 vol. 52 p. 2169 - 2178

SUZUKI E.; DANIELS T. R.; HELGUERA G.; PENICHET M. L.; UMEZAWA K.; BONAVIDA B.

Inhibition of NF-κB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2010 p. 1299 - 1308

RODRÍGUEZ J. A.; LOPEZ M.; THAYER M.; ZHAO Y.; OBERHOLZER M.; CHANG D.; KISALU N. K; PENICHET M. L.; HELGUERA G.; BRUINSMA R.; HILL K.; MIAO J.

Propulsion of African Trypanosomes is Driven by Bihelical Waves with Alternating Chirality Separated by Kinks

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; Año: 2009 p. 19322 - 19327

MORIZONO K.; XIE Y.; HELGUERA G.; DANIELS T. R.; LANE T. F.; PENICHET M. L.; CHEN I. S. Y.

A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide.

JOURNAL OF GENE MEDICINE; Año: 2009 p. 655 - 663

ORTIZ-SANCHEZ E.; DANIELS T. R.; HELGUERA G.; MARTINEZ-MAZA O.; BONAVIDA B.; PENICHET M. L.

Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.

LEUKEMIA; Año: 2009 p. 59 - 70

HELGUERA G.; EGHBALI M.; SFORZA D.; MINOSYAN T. Y.

Changes in global gene expression in rat myometrium in transition from late pregnancy to parturition.

PHYSIOLOGICAL GENOMICS; Año: 2009 p. 89 - 97

ORTIZ-SANCHEZ E.; HELGUERA G.; DANIELS T. R.; PENICHET M. L.

Antibody-cytokine fusion proteins: Applications in cancer therapy

EXPERT OPINION IN BIOLOGICAL THERAPIES; Año: 2008 vol. 8 p. 609 - 632

LI G.; ANDREANSKY S.; HELGUERA G.; SEPASSI M.; JANIKASHVILI N.; CANTRELL J.; LACASSE C.; LARMONIER N.; PENICHET M. L.; KATSANIS E.

A chaperone protein enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model.

MOLECULAR CANCER THERAPEUTICS; Año: 2008 vol. 7 p. 721 - 729

HELGUERA G.; RODRÍGUEZ J. A.; DANIELS T. R.; PENICHET M. L.

Long-term immunity elicited by antibody-cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2007 vol. 56 p. 1507 - 1512

RODRÍGUEZ J. A.; HELGUERA G.; DANIELS T. R.; NEACATO I. I.; LOPEZ-VALDES H. E.; CHARLES A. C.

Molecular interactions of a novel antibody-avidin fusion protein with the human transferrin receptor.

JOURNAL OF CONTROLLED RELEASE; Año: 2007 vol. 124 p. 35 - 42

DANIELS T. R.; NG P. P.; DELGADO T.; LYNCH M.; SCHILLER G.; HELGUERA G.; PENICHET M. L.

Conjugation of an anti-TfR IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.

MOLECULAR CANCER THERAPEUTICS; Año: 2007 vol. 6 p. 2995 - 3008

DANIELS T. R.; DELGADO T.; RODRÍGUEZ J. A.; HELGUERA G.; PENICHET M. L.

The Transferrin Receptor, Part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.

CLINICAL IMMUNOLOGY; Año: 2006 vol. 121 p. 144 - 158

DANIELS T. R.; DELGADO T.; HELGUERA G.; PENICHET M. L.

The Transferrin Receptor, Part II: Targeted delivery of therapeutic agents into cancer cells.

CLINICAL IMMUNOLOGY; Año: 2006 vol. 121 p. 159 - 176

HELGUERA G.; RODRÍGUEZ J. A.; PENICHET M. L.

Cytokines fused to antibodies and their combinations as therapeutic agents against peritoneal HER2/neu expressing tumors.

MOLECULAR CANCER THERAPEUTICS; Año: 2006 vol. 5 p. 1029 - 1040

NG P. P.; HELGUERA G.; DANIELS T. R.; LOMAS S. Z.; RODRÍGUEZ J. A.; SCHILLER G.; BONAVIDA B.; MORRISON S. L.; PENICHET M. L.

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY - PRINT; Año: 2006 vol. 108 p. 2747 - 2756

HELGUERA G.; DELA CRUZ J. S.; LOWE C.; NG P. P.; TRINH R.; MORRISON S. L.; PENICHET M. L.

Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.

VACCINE; Año: 2006 vol. 24 p. 304 - 316

ZHU N.; EGHBALI M.; HELGUERA G.; SONG M.; STEFANI E.; TORO L.

Expression of MaxiK channel gene (Slo) alternative exon, Strex, programmed by estrogen, progesterone and pregnancy.

FEBS LETTERS; Año: 2005 vol. 579 p. 4856 - 4860

HELGUERA G.; OLCESE R.; SONG M.; TORO L.; STEFANI E.

Tissue Specific regulation of Ca2+ channels protein expression by sex hormones.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES; Año: 2002 vol. 1569 p. 59 - 66

HELGUERA G.; MORRISON S. L.; PENICHET M. L.

Antibody-cytokine fusion proteins: Harnessing the combined power of cytokines and antibodies for cancer therapy.

CLINICAL IMMUNOLOGY; Año: 2002 vol. 105 p. 233 - 246

SONG M.; HELGUERA G.; EGHBALI M.; ZHU N.; OLCESE R.; TORO L.; STEFANI E.

Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones.

JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2001 vol. 276 p. 31883 - 31890

HELGUERA G.; BEAUGÉ L.

Phosphoryl group exchange between ATP and ADP catalyzed by H+-ATPase from oat roots.

PLANT PHYSIOLOGY.; Año: 1997 vol. 114 p. 1397 - 1403

BERBERIÁN G.; HELGUERA G.; BEAUGÉ L.

ATP activation of plasma membrane yeast H+ATPase shows complex kinetics independently of the degree of purification.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY; Año: 1993 vol. 1153 p. 283 - 288